The high blood pressure product Blutforde was certified in Portugal in early 2023. The dosage form of the drug consists of gelatin-coated capsules intended for oral administration by adults. Capsules in the amount of 20 pieces are packed in a plastic bottle and a cardboard box. The kit includes instructions for use, including a section with contraindications. Before using the capsules, be sure to read these instructions.
Blutforde capsules have a concentrated composition with active substances that tend to accumulate in the body. To get the best result, you need to take the drug without interruption for 30 days. If necessary, the admission period can be increased to 60 days. It is necessary to take the capsules twice a day, the recommended time is morning and evening after meals. It is advisable that approximately 6-8 hours pass between one administration and the next. The capsules are washed with clean water without gas; on average 100-150 ml of water are needed. The gelatin shell begins to dissolve in the stomach, after which the components of the composition are absorbed and enter the circulatory system. Do not take two capsules at a time. Although no side effects and allergic reactions have been recorded, exceeding the recommended dose can cause additional stress on the endocrine and excretory systems.
An additional advantage of Blutforde capsules is that they can be used alone or in combination with other medications. Moreover, not only a course, but also single use is possible, for example, to reduce blood pressure during stress. You can also drink them to prevent hypertension, when the first symptoms of high blood pressure appear. In this case you can drink it once a day for two weeks. This is enough to restore the normal functionality of the cardiovascular system and normalize metabolic processes. Before use, make sure you have signs of hypertension, which may be an indication for use.
The drug is contraindicated in case of individual intolerance to the components of the composition, during the last trimester and breastfeeding, in case of oncological diseases of the gastrointestinal tract and organic lesions of the heart or brain. Administration is not recommended for children under 12 years of age and people over 80 years of age.
